Physician profile
Iris Maureen Miller
NPI 1912285610
$1,878.12
in general payments reported to CMS, 2019-2025
16 companies · $408 in 2025
The $408 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $153 · 2020: $162 · 2021: $335 · 2022: $166 · 2023: $313 · 2024: $342 · 2025: $408.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,063.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,063.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $477.66 | 2019-2025 | Eysuvis, Rocklatan, Simbrinza |
| Johnson & Johnson Vision Care, INC. | $434.86 | 2019-2025 | Acuvue |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $157.49 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $156.48 | 2021 | |
| Mallinckrodt Hospital Products INC. | $147.11 | 2022-2024 | Acthar |
| Glaukos Corporation | $137.09 | 2024-2025 | Ce-Marked Kxla System, Idosetr |
| Dompe US, INC. | $125.07 | 2025 | Oxervate |
| Sight Sciences, INC. | $39.05 | 2019-2020 | |
| Tarsus Pharmaceuticals, INC. | $35.10 | 2024 | Xdemvy |
| Bausch & Lomb Americas INC. | $34.50 | 2022-2023 | Infuse |
| Allergan, INC. | $33.42 | 2022 | |
| Abb Con-Cise Optical Group LLC | $28.57 | 2021 | |
| Abbvie INC. | $21.42 | 2024 | |
| Oyster Point Pharma, INC. | $19.47 | 2022 | |
| Akorn Operating Company LLC | $16.15 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $14.68 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Iris Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.